| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
foundation_for_the_national_institutes_of_health [2022/04/03 17:46]
liam [Donors] | foundation_for_the_national_institutes_of_health [2022/10/11 23:11] (current)
liam |
|---|
| ===== History ===== | ===== History ===== |
| |
| The FNIH was founded by the [[United_states_congress|U.S. Congress]] in 1990.((Menetski, J. P., Hoffmann, S. C., Cush, S. S., Kamphaus, T. N., Austin, C. P., Herrling, P. L., & Wagner, J. A. (2019). //The Foundation for the National Institutes of Health Biomarkers Consortium: Past accomplishments and new strategic direction.// Clinical Pharmacology & Therapeutics, 105(4), 829–843. https://doi.org/10.1002/cpt.1362)) | The FNIH was founded by the [[United_states_congress|U.S. Congress]] as a not-for-profit 501(c)(3) charitable organization in 1990.((Menetski, J. P., Hoffmann, S. C., Cush, S. S., Kamphaus, T. N., Austin, C. P., Herrling, P. L., & Wagner, J. A. (2019). //The Foundation for the National Institutes of Health Biomarkers Consortium: Past accomplishments and new strategic direction.// Clinical Pharmacology & Therapeutics, 105(4), 829–843. https://doi.org/10.1002/cpt.1362)) Its role is to “support the mission of [[National Institutes of Health]] (NIH) and to advance collaboration with the biomedical researchers from universities, industry and nonprofit organizations.” |
| | |
| | Its role is similar to the [[Reagan-Udall Foundation for the Food and Drug Administration]] or the [[CDC Foundation]], acting as a [[public-private partnership]] in ways that the National Institutes of Health is not ethically or legally empowered to pursue. “Through the years, the FNIH has built alliances and public–private partnerships that have transformed the research landscape and focused on areas in which there is special scientific need for input from the private sector.” |
| |
| ===== COVID-19 ===== | ===== COVID-19 ===== |
| ==== Donors ==== | ==== Donors ==== |
| |
| As listed on the 2020 FNIH donor report.((//2020 Donors.// Foundation for the National Institutes of Health. Retrieved April 2, 2022, from https://web.archive.org/web/20220316135206/https://2020-annual-report.fnih.org/donors/)) | As listed on the 2019 and 2020 FNIH donor reports.((//2020 Donors.// Foundation for the National Institutes of Health. Retrieved April 2, 2022, from https://web.archive.org/web/20220316135206/https://2020-annual-report.fnih.org/donors/)) ((//2019 Donors.// FNIH 2019 Annual Report. Retrieved April 4, 2022, from https://web.archive.org/web/20211008071205/https://2019-annual-report.fnih.org/donors/)) |
| |
| ^ Name ^ Amount ^ Notes ^ | ^ Name ^ Amount ^ Notes ^ |
| | [[Aligning Science Across Parkinson’s]] (ASAP) | $1,000,000 - $2,499,999 | - | | | [[Aligning Science Across Parkinson’s]] (ASAP) | $1,000,000 - $2,499,999 | - | |
| | [[pharmaceutical_companies:Alkermes]] | $25,000 - $49,999 | 2 consecutive years of donations | | | [[pharmaceutical_companies:Alkermes]] | $25,000 - $49,999 | 2 consecutive years of donations | |
| | | [[pharmaceutical_companies:Allergan]] | $500,000 - $999,999 | 2 consecutive years of donations | |
| | [[Alzheimer's Association]] | $2,500,000 - $4,999,999 | 16 consecutive years of donations | | | [[Alzheimer's Association]] | $2,500,000 - $4,999,999 | 16 consecutive years of donations | |
| | [[Alzheimer's Drug Discovery Foundation]] | $250,000 - $499,999 | 8 consecutive years of donations | | | [[Alzheimer's Drug Discovery Foundation]] | $250,000 - $499,999 | 8 consecutive years of donations | |
| | [[pharmaceutical_companies:EMD Serono]] | $100,000 - $249,000 | 5 consecutive years of donations | | | [[pharmaceutical_companies:EMD Serono]] | $100,000 - $249,000 | 5 consecutive years of donations | |
| | [[Gates Ventures]] | $500,000 - $999,999 | 2 consecutive years of donations | | | [[Gates Ventures]] | $500,000 - $999,999 | 2 consecutive years of donations | |
| | | [[GE Healthcare]] | $500,000 - $999,999 | 4 consecutive years of giving | |
| | | [[pharmaceutical_companies:Genentech]] | $1,000,000 - $2,499,999 | 13 consecutive years of giving | |
| | [[pharmaceutical_companies:Gilead Sciences]] | $1,000,000 - $2,499,999 | 5 consecutive years of donations | | | [[pharmaceutical_companies:Gilead Sciences]] | $1,000,000 - $2,499,999 | 5 consecutive years of donations | |
| | [[pharmaceutical_companies:GlaxoSmithKline]] | $5,000,000 - $9,999,999 | 22 consecutive years of donations | | | [[pharmaceutical_companies:GlaxoSmithKline]] | $5,000,000 - $9,999,999 | 22 consecutive years of donations | |
| | [[Verily Life Sciences]] | $250,000 - $499,999 | [[Alphabet]]'s life sciences research subsidiary | | | [[Verily Life Sciences]] | $250,000 - $499,999 | [[Alphabet]]'s life sciences research subsidiary | |
| | [[Wellcome Trust]] | $5,000,000 - $9,999,999 | 2 consecutive years of donations | | | [[Wellcome Trust]] | $5,000,000 - $9,999,999 | 2 consecutive years of donations | |
| | | [[Wyeth Nutrition]] | $500,000 - $999,999 | 5 consecutive years of donations | |
